Search

Your search keyword '"Kim, Youngchul"' showing total 1,120 results

Search Constraints

Start Over You searched for: Author "Kim, Youngchul" Remove constraint Author: "Kim, Youngchul"
1,120 results on '"Kim, Youngchul"'

Search Results

6. Pathogenic Roles for RNASET2 in Clear Cell Renal Cell Carcinoma

14. Habitat escalated adaptive therapy (HEAT): a phase 2 trial utilizing radiomic habitat-directed and genomic-adjusted radiation dose (GARD) optimization for high-grade soft tissue sarcoma

16. Stereotactic radiosurgery and anti-PD-1 + CTLA-4 therapy, anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitors, or conventional chemotherapy for the management of melanoma brain metastases

17. Predicting Limited Survival Following Inguinal Lymph Node Dissection in Penile Cancer: Should We Revisit the Goals of Care?

19. Phase I/II study of stereotactic radiation and sacituzumab govitecan with zimberelimab in the management of metastatic triple negative breast cancer with brain metastases.

26. Data-Sharing Approaches for Achieving Resilient Smart Cities: A Case of Smart City R&D Project in Daegu, South Korea

29. PD16-01 SPATIAL ANALYSIS OF THE TUMOR IMMUNE MICROENVIRONMENT IN PAPILLARY RENAL CELL CARCINOMA

33. PROFILING THE TUMOR IMMUNE MICROENVIRONMENT OF PAPILLARY RENAL CELL CARCINOMA

36. Proteogenomic, Epigenetic, and Clinical Implications of Recurrent Aberrant Splice Variants in Clear Cell Renal Cell Carcinoma

39. Correlating Immune Cell Infiltration Patterns with Recurrent Somatic Mutations in Advanced Clear Cell Renal Cell Carcinoma

41. Evaluation of Patient-Reported Outcomes (PROs) Protocol Content and Reporting for Clinical Trials that Lead to the approval of frontline Immune Checkpoint Blockade Combination for Patients with Advanced Renal Cell Carcinoma - The Patients’ Voice or a Missed Opportunity

42. Talimogene Laherparepvec (T-VEC) for the Treatment of Advanced Locoregional Melanoma After Failure of Immunotherapy: An International Multi-Institutional Experience

43. Feasibility of a Smartphone Application for Education and Symptom Management of Patients With Renal Cell Carcinoma on Combined Tyrosine Kinase and Immune Checkpoint Inhibitors.

48. Oncolytic Virotherapy Combined with Nivolumab Elicits Complete Responses in Muscle-Invasive Bladder Cancer in Association with the Formation of Tertiary Lymphoid Structures

Catalog

Books, media, physical & digital resources